Plus Therapeutics Faces Delisting Concerns
Ticker: PSTV · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, compliance
Related Tickers: PLUS
TL;DR
PLUS is on the verge of getting kicked off NASDAQ.
AI Summary
Plus Therapeutics, Inc. filed an 8-K on June 6, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company's common stock was previously listed on the NASDAQ Capital Market.
Why It Matters
This filing indicates potential issues with the company's ability to remain listed on a major stock exchange, which could impact its stock price and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial stability.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- NASDAQ Capital Market (company) — Stock Exchange
- June 3, 2025 (date) — Earliest event reported
- June 6, 2025 (date) — Filing date
FAQ
What specific listing rule or standard has Plus Therapeutics, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Plus Therapeutics, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What was the date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 3, 2025.
On which stock exchange was Plus Therapeutics, Inc. previously listed?
Plus Therapeutics, Inc. was previously listed on the NASDAQ Capital Market.
What is the filing date of this 8-K report?
This 8-K report was filed on June 6, 2025.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a notice of delisting or failure to satisfy a continued listing rule or standard.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).